14Jul
Mylan and Pfizer’s Upjohn Unit Unveil New Branding For Joint Operation
We have previously reported that Mylan and Upjohn, Pfizer’s off-patent branded and generic business, are combining to form a new company. We also reported that although the planned integration has been delayed because of the COVID-19 pandemic, the transaction is expected to close in the second half of 2020....
By:
Goodwin
Related
This newsletter is our take on the antitrust developments we think are most interesting to your busi...
Read More >
California’s 2019 legislative session recently ended, leaving employers with a number of new laws r...
Read More >
As Coronavirus (COVID-19) continues to ravage the nation’s health and economy, in-progress deals ar...
Read More >
Shareholder Representative Services LLC v. RSI Holdco, LLC, C.A. No. 2018-0517-KSJM (Del. Ch. May 29...
Read More >
Correcting your late deferrals by depositing them and making a contribution to make up for lost earn...
Read More >
The Registrar of Contractors (“ROC”) is likely the most important Arizona agency for businesses in...
Read More >